Carregant...
Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer’s disease
BACKGROUND: The FDA have recently published draft guidance for the development of treatments for early Alzheimer’s disease. Key features of this guidance are the advocacy of sensitive cognitive measures and a taxonomy of disease severity. Whilst desirable patterns of cognitive-functional improvement...
Guardat en:
| Publicat a: | Alzheimers Res Ther |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6026341/ https://ncbi.nlm.nih.gov/pubmed/29958538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0386-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|